When a doctor discovers a nodule on the thyroid, the next question is almost always the same: Is it something to worry about? That question leads to a set of tests, and two of the most common ones people hear about are FNAC and biopsy. People often assume these are the same thing, or that one is simply a more advanced version of the other. That is not quite right, and it is worth understanding the difference before you walk into a consultation wondering what you agreed to.
The thyroid sits at the front of the neck and plays a significant role in regulating metabolism, heart rate, and various other body functions. Nodules on the thyroid are quite common; many adults have them without knowing it. Most are benign, but a small percentage can be malignant, which is why doctors want to examine them more closely when detected.
What the FNAC Test Actually Involves
FNAC stands for Fine Needle Aspiration Cytology. The procedure uses a thin needle to draw out a small amount of fluid or cells from the nodule, which are then examined under a microscope to determine their nature. It is generally done on an outpatient basis, takes only a few minutes, and requires no significant recovery time. There is mild discomfort at the site, but most people find it manageable.
The thyroid FNAC test is considered the standard first step when a nodule appears suspicious on ultrasound, because it provides doctors with insight into the cellular makeup without requiring surgery or a more extensive procedure. This is the kind of information that helps categorise the nodule as benign, indeterminate, or likely malignant. The results are often reported using the Bethesda classification system, a set of categories that describe how the cells appear and what that might mean clinically.
One thing people sometimes miss is that FNAC results can come back as “indeterminate”, meaning the cells do not clearly fall into either the benign or malignant category. This happens more often than expected, particularly with follicular lesions. That is where things can get complicated, and where additional testing becomes relevant.
How a Biopsy Differs — and When It Comes Into the Picture
A biopsy, in general terms, involves taking a tissue sample rather than just cells and examining it under a microscope. In thyroid diagnostics, a core needle biopsy uses a slightly thicker needle to extract a small cylinder of tissue, allowing pathologists to examine tissue architecture rather than just individual cells. This can sometimes provide more information when FNAC results are unclear.
That said, core needle biopsies are not the routine first step for thyroid nodules, as they might be for other organs. They are typically considered when FNAC has been inconclusive or when the clinical picture warrants a second look. Surgical biopsies, where tissue is removed through an operation, go further still and are generally done when there is already a clear plan for surgery, or when other tests have not resolved the diagnostic question.
The key difference to hold onto is this: FNAC collects cells, a biopsy collects tissue, and the level of detail and invasiveness increases accordingly. Most people with thyroid nodules will only need the thyroid FNAC test, and many will never need to go beyond that stage.
When Molecular Testing Adds to the Picture
For those whose FNAC results fall into the indeterminate categories, or for people where the clinical and imaging findings do not fully match the cytology report, molecular testing is now available as an additional layer of information. MedGenome’s ThyroTrack, for instance, analyses genomic biomarkers from FNAC fluid using next-generation sequencing to provide more clarity on the nature of the nodule. This kind of testing does not replace FNAC; it works alongside it, using the same sample, to identify specific genetic mutations that can help guide surgical decisions or rule out unnecessary procedures.
This matters because the alternative, when FNAC is indeterminate, has traditionally been surgery, and thyroid surgery carries its own set of consequences, including the possibility of long-term hormonal management. Having access to genetic information from the same FNAC sample can shift that decision in meaningful ways.
Putting It Together
The thyroid FNAC test is, for most people, the starting point minimally invasive, widely available, and capable of answering the most immediate question about whether a nodule looks concerning. Biopsies come in when more tissue-level detail is needed and are not the standard recommendation for every thyroid nodule. Understanding where each test fits in the process, and what additional options exist when results are not clear-cut, can help people feel more prepared for those conversations with their doctor.
